FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice: A Pictorial Imaging Vignette.

Competing Interests: Funding Support and Author Disclosures Dr Settelmeier has received support from the German Research Foundation (UMEA Junior Clinician Scientist, UMEA Clinician Scientist Academy, FU356/12-2). Dr Varasteh has received support from the German Research Foundation (VA1183/2-1). Dr Rischpler has received a research grant from Pfizer; has received consultancy fees for Adacap and Pfizer; and has received speaker honoraria from Adacap, Alnylam, BTG, Curium, GE Healthcare, Pfizer, and Siemens Healthineers outside of the submitted work. Prof Fendler has received fees from SOFIE Bioscience (research funding), Janssen (consultant and speaker), Calyx (consultant and image review), Bayer (consultant, speaker, and research funding), Novartis (speaker and consultant), Telix (speaker), GE Healthcare (speaker), Eczacıbaşı Monrol (speaker), Abx (speaker), Amgen (speaker), and Urotrials (speaker) outside of the submitted work. Prof Umutlu has served as a speaker/Advisory Board member for Bayer Healthcare and Siemens Healthcare; and has received research grants from Siemens Healthcare outside of the submitted work. Prof Herrmann has received consultant fees from Advanced Accelerator Applications (a Novartis company), Amgen, AstraZeneca, Bain Capital, Bayer, Boston Scientific, Convergent, Curium, Debiopharm, EcoR1, Fusion, GE Healthcare, Immedica, Isotopen Technologien München, Janssen, Merck, Molecular Partners, NVision, POINT Biopharma, Pfizer, Radiopharm Theranostics, Rhine Pharma, Siemens Healthineers, Sofie Biosciences, Telix, Theragnostics, and Y-mAbs; has received research grants from Advanced Accelerator Applications (a Novartis company), Boston Scientific, and Janssen; and holds stock or other ownership interests in AdvanCell, Aktis Oncology, Convergent, NVision, Pharma 15, and Sofie Biosciences outside of the submitted work. Prof Rassaf is supported by the German Research Foundation (DFG RA969/12-1), Ministry of Science and Culture REBIRTH I/II (ZN3440), and Stiftung Gerdes outside of the submitted work. Dr Kersting has received support from the German Research Foundation (UMEA Clinician Scientist Academy, FU356/12-2); has received a research grant from Pfizer; has received funding by the German Research Foundation (DFG, KE2933/1-1); and has received speaker honoraria from Pfizer outside of the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.